SEC 13F Intelligence

Two Sigma Advisers, LP / BSX

Two Sigma Advisers, LP’s Boston Scientific Corp Position

Does Two Sigma Advisers, LP own Boston Scientific Corp (BSX)? Not currently — the last reported position was 6.30M shares worth $601M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$601M
Q4 2025
Shares
6.30M
% of Portfolio
+1.17%
Quarters Held
27
position exited

Position History BSX

Reported value by quarter
Q4 ’18: $23MQ4 ’18Q1 ’19: $80MQ2 ’19: $5MQ3 ’19: $397,000Q4 ’19: $23MQ4 ’19Q1 ’20: $28MQ2 ’20: $46MQ3 ’20: $9MQ4 ’20: $150MQ4 ’20Q1 ’21: $45MQ2 ’21: $239MQ3 ’21: $351MQ4 ’21: $356MQ4 ’21Q1 ’22: $334MQ2 ’22: $165MQ3 ’22: $115MQ4 ’22: $149MQ4 ’22Q1 ’23: $185MQ2 ’23: $146MQ3 ’23: $18MQ2 ’24: $28MQ2 ’24Q3 ’24: $43MQ4 ’24: $67MQ1 ’25: $424MQ2 ’25: $555MQ2 ’25Q3 ’25: $521MQ4 ’25: $601Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 20256.30M$601M+1.17%
Q3 20255.34M$521M+1.04%
Q2 20255.17M$555M+1.14%
Q1 20254.21M$424M+0.96%
Q4 2024755.3K$67M+0.16%
Q3 2024508.5K$43M+0.10%
Q2 2024359.0K$28M+0.06%
Q3 2023337.7K$18M+0.05%
Q2 20232.70M$146M+0.37%
Q1 20233.71M$185M+0.48%
Q4 20223.22M$149M+0.42%
Q3 20222.96M$115M+0.33%
Q2 20224.43M$165M+0.47%
Q1 20227.53M$334M+0.89%
Q4 20218.38M$356M+0.89%
Q3 20218.08M$351M+0.91%
Q2 20215.60M$239M+0.63%
Q1 20211.17M$45M+0.12%
Q4 20204.18M$150M+0.40%
Q3 2020236.7K$9M+0.03%
Q2 20201.32M$46M+0.13%
Q1 2020842.9K$28M+0.11%
Q4 2019503.4K$23M+0.05%
Q3 20199.7K$397,0000.00%
Q2 2019124.8K$5M+0.01%
Q1 20192.09M$80M+0.20%
Q4 2018638.6K$23M+0.06%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Two Sigma Advisers, LP’s full portfolio or all institutional holders of BSX.